JP2009526087A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009526087A5 JP2009526087A5 JP2008555886A JP2008555886A JP2009526087A5 JP 2009526087 A5 JP2009526087 A5 JP 2009526087A5 JP 2008555886 A JP2008555886 A JP 2008555886A JP 2008555886 A JP2008555886 A JP 2008555886A JP 2009526087 A5 JP2009526087 A5 JP 2009526087A5
- Authority
- JP
- Japan
- Prior art keywords
- macrolide
- beta
- agonist
- agent
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003120 macrolide antibiotic agent Substances 0.000 claims 12
- 239000003795 chemical substances by application Substances 0.000 claims 11
- 239000000556 agonist Substances 0.000 claims 10
- 239000003814 drug Substances 0.000 claims 10
- 239000000203 mixture Substances 0.000 claims 10
- 229940079593 drug Drugs 0.000 claims 8
- RXZBMPWDPOLZGW-XMRMVWPWSA-N (E)-roxithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=N/OCOCCOC)/[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 RXZBMPWDPOLZGW-XMRMVWPWSA-N 0.000 claims 6
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 6
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 6
- 229960005224 roxithromycin Drugs 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- OBRNDARFFFHCGE-PERKLWIXSA-N (S,S)-formoterol fumarate Chemical group OC(=O)\C=C\C(O)=O.C1=CC(OC)=CC=C1C[C@H](C)NC[C@@H](O)C1=CC=C(O)C(NC=O)=C1.C1=CC(OC)=CC=C1C[C@H](C)NC[C@@H](O)C1=CC=C(O)C(NC=O)=C1 OBRNDARFFFHCGE-PERKLWIXSA-N 0.000 claims 4
- 102000010907 Cyclooxygenase 2 Human genes 0.000 claims 4
- 108010037462 Cyclooxygenase 2 Proteins 0.000 claims 4
- 229960000193 formoterol fumarate Drugs 0.000 claims 4
- 241000124008 Mammalia Species 0.000 claims 3
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 claims 3
- 229960004099 azithromycin Drugs 0.000 claims 3
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 claims 2
- 229960003060 bambuterol Drugs 0.000 claims 2
- ANZXOIAKUNOVQU-UHFFFAOYSA-N bambuterol Chemical group CN(C)C(=O)OC1=CC(OC(=O)N(C)C)=CC(C(O)CNC(C)(C)C)=C1 ANZXOIAKUNOVQU-UHFFFAOYSA-N 0.000 claims 2
- 229960002626 clarithromycin Drugs 0.000 claims 2
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 2
- 239000002599 prostaglandin synthase inhibitor Substances 0.000 claims 2
- 229960002052 salbutamol Drugs 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- 229940122204 Cyclooxygenase inhibitor Drugs 0.000 claims 1
- 230000036528 appetite Effects 0.000 claims 1
- 235000019789 appetite Nutrition 0.000 claims 1
- 229960004296 megestrol acetate Drugs 0.000 claims 1
- RQZAXGRLVPAYTJ-GQFGMJRRSA-N megestrol acetate Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RQZAXGRLVPAYTJ-GQFGMJRRSA-N 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75311805P | 2005-12-22 | 2005-12-22 | |
| US77275206P | 2006-02-13 | 2006-02-13 | |
| PCT/IB2006/004315 WO2008093148A2 (en) | 2005-12-22 | 2006-12-20 | Compositions and methods for prevention and treatment of cachexia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009526087A JP2009526087A (ja) | 2009-07-16 |
| JP2009526087A5 true JP2009526087A5 (enExample) | 2010-01-07 |
Family
ID=38194678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008555886A Withdrawn JP2009526087A (ja) | 2005-12-22 | 2006-12-20 | 悪液質の予防および処置のための組成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8080528B2 (enExample) |
| EP (1) | EP1991270A4 (enExample) |
| JP (1) | JP2009526087A (enExample) |
| MX (1) | MX2008007790A (enExample) |
| NO (1) | NO20083240L (enExample) |
| WO (1) | WO2008093148A2 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000021509A2 (en) * | 1998-10-15 | 2000-04-20 | Imperial College Innovations Limited | Methods of treatment |
| GB0624282D0 (en) | 2006-12-05 | 2007-01-10 | Cavalla David | Treatment of cachexia |
| EP2155180B1 (en) * | 2007-04-24 | 2016-07-13 | Acacia Pharma Limited | Drug combination and its use in the treatment of muscle loss |
| US8252286B2 (en) | 2007-05-21 | 2012-08-28 | Alderbio Holdings Llc | Antagonists of IL-6 to prevent or treat thrombosis |
| US9701747B2 (en) | 2007-05-21 | 2017-07-11 | Alderbio Holdings Llc | Method of improving patient survivability and quality of life by anti-IL-6 antibody administration |
| ES2721753T3 (es) | 2007-05-21 | 2019-08-05 | Alderbio Holdings Llc | Anticuerpos contra IL-6 y usos de los mismos |
| US8404235B2 (en) | 2007-05-21 | 2013-03-26 | Alderbio Holdings Llc | Antagonists of IL-6 to raise albumin and/or lower CRP |
| US8178101B2 (en) | 2007-05-21 | 2012-05-15 | Alderbio Holdings Inc. | Use of anti-IL-6 antibodies having specific binding properties to treat cachexia |
| US8062864B2 (en) | 2007-05-21 | 2011-11-22 | Alderbio Holdings Llc | Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies |
| US7906117B2 (en) | 2007-05-21 | 2011-03-15 | Alderbio Holdings Llc | Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever |
| US20090221518A1 (en) * | 2007-11-18 | 2009-09-03 | Anaborex, Inc. | Compositions and Methods for Treatment of Exudative Serous Effusion |
| US8257684B2 (en) * | 2008-03-26 | 2012-09-04 | Neurosigma, Inc. | Methods for identifying and targeting autonomic brain regions |
| JP5620918B2 (ja) * | 2008-11-25 | 2014-11-05 | ブリストル・マイヤーズ スクイブ カンパニー | アルブミンを上昇および／またはｃｒｐを低下させるためのｉｌ−６アンタゴニスト |
| US8323649B2 (en) | 2008-11-25 | 2012-12-04 | Alderbio Holdings Llc | Antibodies to IL-6 and use thereof |
| US8992920B2 (en) | 2008-11-25 | 2015-03-31 | Alderbio Holdings Llc | Anti-IL-6 antibodies for the treatment of arthritis |
| US8337847B2 (en) | 2008-11-25 | 2012-12-25 | Alderbio Holdings Llc | Methods of treating anemia using anti-IL-6 antibodies |
| US9452227B2 (en) | 2008-11-25 | 2016-09-27 | Alderbio Holdings Llc | Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments |
| US8420089B2 (en) | 2008-11-25 | 2013-04-16 | Alderbio Holdings Llc | Antagonists of IL-6 to raise albumin and/or lower CRP |
| US9212223B2 (en) | 2008-11-25 | 2015-12-15 | Alderbio Holdings Llc | Antagonists of IL-6 to prevent or treat thrombosis |
| WO2011066371A2 (en) | 2009-11-24 | 2011-06-03 | Alder Biopharmaceuticals, Inc. | Antibodies to il-6 and use thereof |
| US9775921B2 (en) | 2009-11-24 | 2017-10-03 | Alderbio Holdings Llc | Subcutaneously administrable composition containing anti-IL-6 antibody |
| WO2012009542A2 (en) * | 2010-07-14 | 2012-01-19 | Kansas State University Research Foundation | Methods for alleviating chronic pain and improving performance of cattle undergoing dehorning or castration |
| WO2012071561A2 (en) | 2010-11-23 | 2012-05-31 | Alder Biopharmaceuticals, Inc. | Anti-il-6 antibodies for the treatment of anemia |
| JP2015512902A (ja) * | 2012-03-28 | 2015-04-30 | アフィボディ・アーベー | 経口投与 |
| WO2020018554A1 (en) * | 2018-07-17 | 2020-01-23 | The Regents Of The University Of California | Methods of treating renal disease |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4859782A (en) * | 1986-06-26 | 1989-08-22 | Harbor Branch Oceanographic Institution, Inc. | Misakinolide compositions and their derivatives |
| EP0662324A1 (en) | 1987-09-15 | 1995-07-12 | The Rowett Research Institute | Use of beta-adrenergic agonists for treating loss of function of striated muscles |
| HUT50044A (en) | 1988-04-12 | 1989-12-28 | Bristol Myers Co | Process for producing pharmaceutical composition comprising megestrol acetate as active ingredient |
| US5252564A (en) * | 1991-03-29 | 1993-10-12 | The United States Of America As Represented By The Secretary Of Agriculture | Method to decrease cortisol secretion by feeding melengesterol acetate |
| CA2194049A1 (en) * | 1994-06-28 | 1996-01-11 | Georgi Stankov | Novel clinical uses of polyene macrolides |
| US5750493A (en) * | 1995-08-30 | 1998-05-12 | Raymond F. Schinazi | Method to improve the biological and antiviral activity of protease inhibitors |
| US6706892B1 (en) * | 1999-09-07 | 2004-03-16 | Conjuchem, Inc. | Pulmonary delivery for bioconjugation |
| US7101576B2 (en) * | 2002-04-12 | 2006-09-05 | Elan Pharma International Limited | Nanoparticulate megestrol formulations |
| US7211568B2 (en) | 2003-12-18 | 2007-05-01 | Kosan Biosciences Incorporated | 9-Desoxoerythromycin compounds as prokinetic agents |
| WO2008004224A2 (en) | 2006-07-03 | 2008-01-10 | Arie Levine | Synergistic compositions for crohn's disease and inflammatory gastrointestinal disorders |
-
2006
- 2006-12-20 EP EP06852000A patent/EP1991270A4/en not_active Withdrawn
- 2006-12-20 MX MX2008007790A patent/MX2008007790A/es not_active Application Discontinuation
- 2006-12-20 US US11/614,056 patent/US8080528B2/en not_active Expired - Fee Related
- 2006-12-20 JP JP2008555886A patent/JP2009526087A/ja not_active Withdrawn
- 2006-12-20 WO PCT/IB2006/004315 patent/WO2008093148A2/en not_active Ceased
-
2008
- 2008-07-22 NO NO20083240A patent/NO20083240L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009526087A5 (enExample) | ||
| WO2007112274A3 (en) | Formulations of low dose non-steroidal anti-inflammatory drugs and beta-cyclodextrin | |
| Karthi et al. | NSAIDs in orthodontic tooth movement | |
| HRP20180300T1 (hr) | Modulatori atp-vezujućih kasetnih transportera | |
| IL194885A0 (en) | Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and an nsaid | |
| JP2006504795A5 (enExample) | ||
| JP2007536311A5 (enExample) | ||
| EE05129B1 (et) | Konjugeeritud strogeenide ja medroksprogesteroonatsetaadi kasutamine, farmatseutiline kompositsioon, doseerimishik ja pakend | |
| HRP20160189T1 (hr) | Liječenje crohnove bolesti lakvinimodom | |
| JP2007513165A5 (enExample) | ||
| JP2008528510A5 (enExample) | ||
| JP2006526644A5 (enExample) | ||
| DK2083889T3 (da) | Doserings- og drivmekanisme til lægemiddeladministrationsanordning | |
| JP2009525343A5 (enExample) | ||
| JP2006526626A5 (enExample) | ||
| JP2007514005A5 (enExample) | ||
| JP2013505282A5 (enExample) | ||
| WO2014189836A1 (en) | Therapeutic and method of use | |
| WO2007106550A3 (en) | Methods and compositions for deterring abuse of orally administered pharmaceutical products | |
| HRP20171739T1 (hr) | Postupci i kompozicije za liječenje simptoma povezanih s posttraumatskim stresnim poremećajem korištenjem ciklobenzaprina | |
| WO2007012019A3 (en) | Medicaments containing famotidine and ibuprofen and administration of same | |
| JP2015510928A5 (enExample) | ||
| BRPI0509276A (pt) | medicamentos de sabor disfarçado em multiparticulados de ruptura | |
| AR058194A1 (es) | Medicamentos que comprenden un agente antimuscarinico y un corticoesteroide | |
| JP2009517411A5 (enExample) |